Tuyển tập các báo cáo nghiên cứu về y học được đăng trên tạp chí y học Critical Care giúp cho các bạn có thêm kiến thức về ngành y học đề tài: Clinical and Molecular Allergy: a new open access journal that addresses rapidly evolving information in the field of allergy and immunology. | Clinical and Molecular Allergy BioMed Central Editorial Open Access Clinical and Molecular Allergy a new open access journal that addresses rapidly evolving information in the field of allergy and immunology Guha Krishnaswamy 1 and David S Chi2 Address 1Professor of Medicine Chief of Allergy and Immunology James H. Quillen College of Medicine East Tennessee State University USA and 2Professor of Medicine and Chief Biomedical Research James H. Quillen College of Medicine East Tennessee State University USA Email Guha Krishnaswamy - krishnas@ David S Chi - chi@ Corresponding author Published 04 February 2004 Received 23 January 2004 Accepted 04 February 2004 Clinical and Molecular Allergy 2004 2 1 This article is available from http content 2 1 1 2004 Krishnaswamy and Chi licensee BioMed Central Ltd. This is an Open Access article verbatim copying and redistribution of this article are permitted in all media for any purpose provided this notice is preserved along with the article s original URL. Clinical and Molecular Allergy is an Open Access peer-reviewed online journal that addresses all clinical and molecular aspects of allergic disease. The genomics revolution of the 21st century has led to enormous advances in our understanding of allergic and immunological disease. The use of transgenic and knock out methodologies stem cell biology gene cloning and sequencing and high throughput technology has revolutionized medicine. Discovery of families of cytokines and chemokines novel signaling mechanisms and of new mediators and inflammatory pathways have led to pivotal insights into the basis of allergic and immunological diseases. This has led to the generation of new treatment strategies such as monoclonal antibodies cytokine inhibitors new immunomodulators and gene therapy. At present there is no journal dedicated specifically to both the clinical and molecular aspects of allergic diseases. In starting Clinical and .
